West and Central Africa

Faith-based organizations play a key role in all areas of the HIV response and provide a significant part of HIV-related health care through their networks of hospitals, clinics and community systems, particularly in high-burden countries. For this reason, UNAIDS and the United States President’s Emergency Plan for AIDS Relief (PEPFAR) launched a joint initiative to capitalize on the global and national leadership of faith-based organizations and to harness the power that a network of faith-based organizations could offer in some countries, including Côte d’Ivoire.

The UNAIDS–PEPFAR faith-based initiative was launched in Côte d’Ivoire on 14 October 2020 under the leadership of the Ministry of Health and Public Hygiene through the national AIDS control programme.

Following the national launch, several activities were initiated in the country as part of the initiative. These include the ongoing development of the Faith-Based Action Plan, under the leadership of the national AIDS control programme, which aims to ensure effective coordination and close monitoring of programmes, as well as synergy and complementarity in their implementation.

Caritas Côte d’Ivoire, which is a member of Caritas Internationalis, the organization in charge of implementing the social doctrine of the Catholic Church at the global and country levels, launched the GRAIL (Galvanizing Religious Actors for Better Identification and Linkage to Paediatric HIV) project on 9 February. This project will strengthen the involvement of faith-based organizations in accelerating the early diagnosis and treatment of children living with HIV in Côte d’Ivoire.

During the launch of the GRAIL project, a representative of the Ministry of Health and Public Hygiene welcomed the commitment of the Catholic Church in the national response to HIV and recalled the place of paediatric AIDS in national priorities.

“The COVID-19 pandemic that we are facing is a very worrying health and social emergency that requires a strong response. Many of the people affected are children living with HIV,” said Bruno Yedoh Essoh, the President of Caritas Côte d’Ivoire.

“Gaps in the diagnosis and care of children living with HIV are notable and an effective national partnership with faith-based organizations in Côte d’Ivoire can help fill these gaps,” said Jean-François Somé, a UNAIDS PEPFAR/Global Fund to Fight AIDS, Tuberculosis and Malaria Implementation Adviser who represented UNAIDS at the launch.

The GRAIL project will focus on training religious leaders and faith-based health service providers on paediatric HIV and on actions to reduce stigma and discrimination against people living with HIV, including children. The first session of a training workshop for religious leaders and faith-based health service providers on paediatric AIDS started immediately after the launch of the GRAIL project. Other training sessions are planned around the country.

The Global Fund to Fight AIDS, Tuberculosis and Malaria, the Government of Congo and health partners have announced two new grants worth more than US$ 64 million to strengthen prevention and treatment services to respond to HIV, tuberculosis and malaria and to build resilient and sustainable systems for health in Congo.

The two grants are a 97% increase from the previous allocation against the three diseases and will be spent from 2021 to 2023.

“UNAIDS looks forward to continuing to work closely with all partners to accelerate the elimination of vertical transmission of HIV and paediatric AIDS in Congo and to improve access to HIV/tuberculosis programmes, sexual and reproductive health, and legal services for young women and adolescent girls and all groups at higher risk of contracting HIV,” said Winnie Byanyima, Executive Director of UNAIDS.

The HIV grant will significantly increase the number of people living with HIV who know their HIV status and will expand access to life-saving antiretroviral therapy, particularly for pregnant women. In 2019 in Congo, only 51% of people living with HIV knew their HIV status and only 25% of people living with HIV were accessing antiretroviral therapy. Only 10% of pregnant women living with HIV in Congo were offered antiretroviral medicine to prevent the virus being passed to their babies.

The tuberculosis component of the grant aims to boost the national tuberculosis response, increase the notification of new tuberculosis cases and reach a 90% treatment success rate by 2023, in line with the World Health Organization’s End TB Strategy. The grant will also support the country’s efforts to improve treatment success for people with multidrug-resistant tuberculosis. The malaria grant will support the country’s goal to distribute 3.5 million mosquito nets by 2023 and expand access to quality malaria diagnostics and treatment tools.

“In the context of the country’s financial crisis, exacerbated by the COVID-19 pandemic, the grants allocated to Congo are a breath of fresh air. They provide renewed impetus to the government’s action in favour of populations affected by HIV, tuberculosis and malaria,” said the Prime Minister of Congo, Clément Mouamba.

The United Nations Development Programme will implement the HIV and tuberculosis grant, while Catholic Relief Services will implement the malaria grant.

The 34th Ordinary Assembly of the African Union Heads of States and Government was held virtually on 6 and 7 February 2021.

The President of the Democratic Republic of the Congo and new Chair of the African Union, Félix Tshisekedi, pictured above, urged Member States not to forget devastating global epidemics, such as malaria and AIDS, and learn from them to strengthen health systems, including the reinforcement of the Africa Centers for Disease Control and Prevention. 

“Leveraging the experiences we have gained in the fight against adversity and our ability to adapt, we should not give up. Let us not forget other pandemics, often more deadly, that are still affecting the continent, like malaria and HIV,” said the President of the Democratic Republic of the Congo.

The assembly recognized the African Union’s role in mounting a united, innovative and strong partnership among Member States to address the COVID-19 pandemic, which has had a significant economic impact on Africa and further weakened its health systems.

Heads of states committed to sustaining efforts to curb the spread of the virus and mitigate its socioeconomic impact by using the Africa Continental Free Trade Agreement and to implement a coordinated vaccination programme through the Africa Vaccine Acquisition Task Team to ensure that no country is left behind.

“In responding to the pandemic, we have been at the forefront of innovation. We established the groundbreaking Africa Medical Supplies Platform to assist African Union Member States to access affordable medical supplies and equipment,” said the President of South Africa, Cyril Ramaphosa, pictured above.

The President of South Africa commended heads of states for their extraordinary and decisive leadership in tackling the COVID-19 crisis. He expressed dismay at the increase in violence against women and called on the continental body to prioritize women’s economic empowerment and develop a convention to promote, protect and fulfil women’s rights. He called on Member States to ratify International Labour Organization Convention No. 190 on eliminating harassment and violence in the world of work. 

Aside from the African Union Chair’s handover from South Africa to the Democratic Republic of the Congo, the two-day assembly marked critical decisions on the implementation of the African Union’s institutional reform, including its Commission, and the election of four new commissioners. Moussa Faki Mahamat was re-elected as the African Union Commission Chairperson for a second four-year term and newly elected Monique Nsanzabaganwa, the first female in the history of the Commission, as his deputy. 

“I congratulate the President of the Democratic Republic of the Congo, Félix Tshisekedi, for taking the reins as the Chair of the African Union for 2021 and commend him for calling on his peers to sustain efforts in the AIDS response and strengthen health systems in Africa while we are still facing the COVID-19 pandemic. I reaffirm UNAIDS’ support to the African Union. Saving lives, tackling inequalities and advancing universal health care are lessons learned from AIDS to address current and future pandemics successfully,” said Clémence Aissatou Habi Baré, Director of the UNAIDS Liaison Office to the African Union and United Nations Economic Commission for Africa.

The presidential and legislative elections in the Central African Republic on 27 December 2020 were meant to mark the consolidation of democracy and bolster economic and social recovery in a country tormented by decades of conflict and humanitarian challenges. However, the electoral process has given way to a serious political and military crisis, with the resurgence of armed conflict and a blockade of the main trade and supply routes to the landlocked country by rebel groups.

It is in this context of crisis, and in the aftermath of bloody clashes between armed groups and government forces on the outskirts of the capital, Bangui, that the UNAIDS country office in the Central African Republic hosted a workshop to produce HIV estimates for the country from 18 to 22 January. This important annual exercise is conducted by UNAIDS with national authorities in all regions of the world to provide countries and HIV stakeholders with essential data on the pandemic and the response.

Marie Charlotte Banthas, the Director of Disease Control at the Ministry of Health, oversees HIV and tuberculosis treatment programmes in the Central African Republic. Over the past three years, her services have been at the forefront of efforts to accelerate access to antiretroviral therapy from some 25 000 people on treatment in 2016 to more than 48 000 in June 2020. A former head of monitoring and evaluation at the Ministry of Health, she considers the HIV estimates workshop a priority, despite the deteriorated security situation. “There is no effective response to HIV without data. We need to hold this workshop to provide the country with reliable data to better guide our efforts and improve the care of our patients,” she said. 

Civil society also considers HIV estimates as a crucial endeavour. Bertille Zemangui is the President of the National Network of Free Girls, a sex workers’ organization representing key populations. To attend the HIV workshop, Ms Zemangui had to travel long distances each day through sensitive areas. The increased cost of public transport due to the crisis was not enough to discourage Ms Zemangui and other workshop participants. “The current situation is difficult. Everything has become expensive: transportation, food. But we have to be there to make our voice heard because it is sex workers and other key populations that are most affected by HIV in the Central African Republic,” she said. According to data from a 2019 survey, HIV prevalence among sex workers is 15% and 6.5% among gay men and other men who have sex with men, compared to 3.5% among all adults in the country. 

For security reasons, the estimates workshop was moved to the UNAIDS office and participation was reduced to national and international experts and members of civil society. “This workshop provided us with a clearer idea of the magnitude and trajectory of the epidemic for 2021. These are essential to measuring our progress towards achieving the 95–95–95 goals,” said Marcel Massanga, the Deputy National Coordinator of the National AIDS Control Council. The workshop also served to identify approaches to improve the quality and completeness of HIV data in the Central African Republic. Thus, the participants agreed on the need to integrate HIV data into the District Health Information System 2 (DHIS2) platform with a view to strengthening the health system. 

There are concerns that the volatile security situation could jeopardize the Central African Republic’s efforts to accelerate its HIV response. In 2020, the country launched an ambitious National HIV Strategic Plan 2021–2025, which aims to eliminate discrimination, halve new HIV infections and ensure that 95% of people living with HIV access antiretroviral therapy by 2025. “It will not be possible to achieve these ambitious goals without peace and stability. Already we have information that in several areas people living with HIV have fled into the bush and are without treatment. We must quickly implement contingency plans to respond to these emergencies,” said Patrick Eba, the UNAIDS Country Director for the Central African Republic.

The Centre de Prise en Charge Intégrée des Addictions de Dakar (CEPIAD), which opened in December 2014, is an addiction reference centre in Dakar for Senegal and the wider region. To date, it has cared for 1200 people, including approximately 250 people currently enrolled on its opioid substitution therapy programme.

In Senegal, HIV prevalence among people who inject drugs is 3.7%, well above the average of 0.4% among the general population. HIV prevalence is higher among female drug users (13%) than among men (3%), but women represent less than 10% of CEPIAD’s active caseload. In response, CEPIAD has reached out to women who inject drugs. With the support of UNAIDS, and in collaboration with the Conseil National De Lutte Contre le Sida, CEPIAD organized a week of activities around World AIDS Day to address the specific needs of women.

“Women were at the heart of the organization of this week. We want to remove the misrepresentations and misunderstandings that hinder their attendance at the centre,” said Ibrahima Ndiaye, Deputy Coordinator of CEPIAD.

Women were able to access HIV and hepatitis C screening services, gynaecology consultations, including cervical cancer screening, and addiction counselling. Talks with female drug users and a debate on harm reduction were organized on 1 December, World AIDS Day.

A three-day training on making soap, using honey, aloe vera, shea butter, palm oil and mbeurbeuf, and a batik workshop were also offered. More than 50 women participated and the products were sold on the closing day of the week of activities.

Ndeye Khady, the founder of the batik workshop, is a former crack smoker who is currently accessing opioid substitution therapy and antiretroviral therapy at CEPIAD, where she met her husband, also a former drug user. “My dream now is to have a child. I am so grateful that I have been able to take advantage of the services offered. I encourage more women to use them,” she said.

On World AIDS Day, the UNAIDS Executive Director visited an HIV community village and a children’s hospital

Kinshasa, 2 December 2020—UNAIDS Executive Director Winnie Byanyima visited an HIV community village in Kinshasa as part of the World AIDS Day ceremonies in the capital of the Democratic Republic of the Congo. She commended the country on its vast experience in responding to pandemics such as Ebola after the country announced the end of the latest Ebola outbreak on 18 November.

“I thank the Congolese government, our friends from civil society and partners who together have enabled the country to respond to its many challenges, particularly HIV, Ebola and now COVID-19,” said Ms Byanyima.

Ms Byanyima stressed that more people in the country need life-saving HIV treatment and that more needs to be done to support women in particular. “Despite considerable progress, only 57% of people living with HIV are on antiretroviral therapy,” Ms Byanyima said. “Coverage of antiretroviral therapy is higher among men (72%) than among women (51%), a real sign of gender inequality.” She added that if women do not feel safe to disclose their HIV status or feel that they will be supported or accepted if they are living with HIV, they will not enrol onto HIV treatment.

Out of the 520 000 people living with HIV in the Democratic Republic of the Congo, more than 64% are women. There are 68 000 children under the age of 14 years who are living with HIV in the country, of whom only 25% are on treatment, which is why Ms Byanyima called on the country to accelerate paediatric care, including HIV services.

At the Kalembelembe Children’s Hospital she spoke to staff and adolescents who have grown up accessing care and support at its paediatric centre. The adolescents asked the Executive Director to continue to advocate for funding to maintain peer support groups for adolescents living with HIV, the elimination of user fees, the inclusion of all adolescents living with HIV in education and the elimination of legal barriers requiring parental consent for HIV testing for adolescents.

HIV in the Democratic Republic of the Congo, like in the rest of sub-Saharan Africa, particularly affects young women. Ms Byanyima reiterated that to end AIDS, the focus must be put on women and girls. “Every week, 4500 young women in sub-Saharan Africa are infected with HIV,” she said. “This is unacceptable, we need to make a radical difference in the response to HIV.”

Upon her arrival in Kinshasa, Ms Byanyima met with the Minister of Health, Eteni Longondo. She congratulated him on his leadership in responding to COVID-19 and shared her concerns about keeping HIV at the top of the agenda, despite the multitude of pressures of the three colliding pandemics of Ebola, HIV and COVID-19. 

AIDS-related deaths in the Democratic Republic of the Congo have dropped by 61% in the past 10 years, from 37 000 in 2010 to 15 000 in 2019.  HIV prevalence hovers around 1% among adults, but 23 000 people became newly infected with HIV last year. 

Bold ambitious targets

UNAIDS’ new report, Prevailing against pandemics by putting people at the centre, calls on countries to make far greater investments in global pandemic responses and to adopt a new set of bold, ambitious but achievable HIV targets. If those targets are met, the world will be back on track to ending AIDS as a public health threat by 2030.

The global AIDS response was off track before the COVID-19 pandemic hit, but the rapid spread of the coronavirus has created additional setbacks. Modelling of the pandemic’s long-term impact on the HIV response shows that there could be an estimated 123 000 to 293 000 additional new HIV infections and 69 000 to 148 000 additional AIDS-related deaths between 2020 and 2022.

“The collective failure to invest sufficiently in comprehensive, rights-based, people-centred HIV responses has come at a terrible price,” said Winnie Byanyima, Executive Director of UNAIDS. “Implementing just the most politically palatable programmes will not turn the tide against COVID-19 or end AIDS. To get the global response back on track will require putting people first and tackling the inequalities on which epidemics thrive.”

Getting back on track

Although some countries in sub-Saharan Africa, such as Botswana and Eswatini, have done remarkably well and have achieved or even exceeded the HIV targets set for 2020, many more countries are falling way behind. The high-performing countries have created a path for others to follow. UNAIDS has worked with its partners to distil those lessons into a set of proposed targets for 2025 that take a people-centred approach.

The targets focus on a high coverage of HIV and reproductive and sexual health services together with the removal of punitive laws and policies and on reducing stigma and discrimination. They put people at the centre, especially the people most at risk and the marginalized—young women and girls, adolescents, sex workers, transgender people, people who inject drugs and gay men and other men who have sex with men.

New HIV service delivery targets aim at achieving a 95% coverage for each sub-population of people living with and at increased risk of HIV. By taking a person-centred approach and focusing on the hotspots, countries will be better placed to control their epidemics.

The 2025 targets also require ensuring a conducive environment for an effective HIV response and include ambitious antidiscrimination targets so that less than 10% of countries have punitive laws and policies, less than 10% of people living with and affected by HIV experience stigma and discrimination and less than 10% experience gender inequality and violence.

Côte d’Ivoire has launched its Harnessing the Power of Partnerships faith-based initiative.

As one of several focus countries for an initiative of the United States President’s Emergency Plan For AIDS Relief (PEPFAR) and UNAIDS, which was launched in June 2020 to leverage global and country leadership by faith-based organizations in the HIV response, Côte d’Ivoire will work with faith-based organizations in the country to align their activities to faith action plans in support of the national HIV response. Experience shows that such an alignment results in a better coordinated and sustained participation of the faith sector in national responses to HIV.

Faith-based organizations have always played an important role in the response to HIV through their strong links with communities and their broad network of hospitals, clinics and other health facilities. However, to unleash the full potential of those organizations, there is still a need to reinforce their capacities to adopt new policies and innovations, to improve their collaboration and coordination with partners in the HIV response and to further address HIV-related stigma and discrimination within faith communities.

“This initiative will build on the global and national leadership of faith-based organizations in the response to HIV, with a particular focus on areas where faith-based organizations have a real and sustainable impact,” said Samba Mamadou, Director-General of the Côte d’Ivoire Ministry of Health and Public Hygiene.

Through the partnership, PEPFAR’s implementing partners in the country will work with faith-based organizations to develop messages of hope to reduce HIV-related stigma and discrimination and increase demand for HIV services. Key issues to be addressed will include treatment cessation through “faith healing” and the need for strengthened HIV literacy.

The next steps of the initiative include convening a meeting with all the relevant stakeholders to develop a faith action plan in support of the national HIV strategic plan for 2021–2025.

“The initiative is designed as a consortium of longstanding faith-based organizations and partners working together to build and combine their strengths, promote evidence-informed policy and practice and strengthen advocacy efforts,” said Brigitte Quenum, UNAIDS Country Director for Côte d’Ivoire.

The initiative, which is under the leadership of the Ministry of Health and Public Hygiene and the National AIDS Control Program, and is supported by UNAIDS, was launched in mid-October at an event attended by more than 50 partners that was hosted by UNAIDS and streamed online. 

"The faith-baith institutions welcome this interfaith initiative to strengthen the contribution of our institutions and leaders in a more synergistic way,” said Pastor Yapi, Deputy Vice-President of the Alliance des Religieux pour la Santé Intégrale et la Promotion de la Personne Humaine.

GENEVA, 9 November 2020—UNAIDS is strongly encouraged by new study results showing that the antiretroviral medicine cabotegravir, which is administered by injection every two months, prevents HIV among women. The study shows that the long-acting injections among women in sub-Saharan Africa were 89% more efficient in preventing HIV compared to daily tablets of pre-exposure prophylaxis (PrEP).

“These results are hugely significant. UNAIDS has long been calling for additional, acceptable and effective HIV prevention options for women, and this could be a real game-changer,” said Winnie Byanyima, Executive Director of UNAIDS. “If donors and countries invest in rolling out access of injectable PrEP to women at higher risk of HIV, new infections could be dramatically reduced.”

The trial enrolled over 3200 women aged between 18 and 45 years who were at higher risk of acquiring HIV in Botswana, Kenya, Malawi, South Africa, Eswatini, Uganda and Zimbabwe. The trial was halted early on the recommendation of the Data and Safety Monitoring Board due to clear statistical evidence showing that the injectable medicine is more effective than a daily pill.

Four HIV infections occurred among women randomly assigned to the cabotegravir injectable arm of the study, compared to 34 infections in the arm that was randomly assigned to daily oral PrEP. The risk of HIV was ninefold lower with cabotegravir injections than with daily oral PrEP.

The study results are important and timely as more methods to prevent HIV among women at higher risk of HIV are urgently needed, including methods that do not depend on daily or near-daily pill-taking, condom use or abstention from sex. The development of alternative methods to prevent HIV, and more adherence-friendly schedules than are currently available, will increase the HIV prevention choices and acceptability for women and reduce new HIV infections.

“UNAIDS congratulates everyone involved in this landmark study,” said Ms Byanyima. “Like with a COVID-19 vaccine, we now must work to ensure that these life-changing injections are accessible, affordable and equitably distributed to people who choose to use them.”

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

A critical component of HIV responses is ensuring that young people know both how to prevent HIV infections and where they can safely access HIV prevention and sexual and reproductive health services.

An analysis of population-based surveys conducted since 2000 suggests that comprehensive knowledge of HIV among young women and men in western and central Africa—and men in eastern and southern Africa—has steadily risen. However, comprehensive knowledge of HIV among young women in eastern and southern Africa has increased at a slower rate.

Recent surveys show that there is still significant work to be done. Among surveys conducted between 2011 and 2018, just 39% of young women (aged 15 to 24 years) in eastern and southern Africa—and 28% in western and central Africa—demonstrated comprehensive knowledge of HIV, compared to 46% and 31% of young men in the same age group, respectively. In 2001, countries committed in the Declaration of Commitment on HIV/AIDS to ensure that, by 2005, 90%, and, by 2010, 95% of young people aged 15–24 years have information, education, services and life skills that enable them to reduce their vulnerability to HIV infection.

GENEVA, 16 October 2020—The President of Nigeria, Muhammadu Buhari, has announced that Nigeria will be joining the urgent global call for a People’s Vaccine for COVID-19. The President endorsed the initiative and released an official public statement in favour of the campaign.

“Learning from the painful lessons from a history of unequal access in dealing with diseases such as HIV we must heed the warning that “those who do not remember the past are doomed to repeat it”,” said Mr Buhari. “Only a People’s Vaccine with equality and solidarity at its core can protect all of humanity and get our societies safely running again. A bold international agreement cannot wait.”

Nigeria is the most populous country in Africa, home to more than 200 million people, and has the third highest number of COVID-19 cases in Africa after South Africa and Ethiopia. In March 2020, Mr Buhari set up a multisectoral Presidential Task Force to combat the COVID-19 pandemic, which produced a mid-term report in July 2020 outlining a significant body of work undertaken to stop the spread of COVID-19.

However, the report also shows that the health infrastructure and equipment levels in Nigeria are not strong enough to support a sustained national response to COVID-19 and that if the pandemic were to spread exponentially Nigeria would struggle to mount an effective response. This demonstrates the urgent need for access to a vaccine for COVID-19 in Nigeria as soon as it becomes available.

“UNAIDS and other members of the People’s Vaccine Alliance are calling for a new approach that puts public health first by sharing knowledge and maximizing supply to make sure that no one is left behind,” said Winnie Byanyima, Executive Director of UNAIDS. “Anything short of that will lead to more deaths and economic chaos, forcing millions into destitution.”

The People’s Vaccine Alliance is a coalition of organizations and activists united under a common aim of campaigning for a People’s Vaccine for COVID-19. In support of actions taken by the World Health Organization (WHO), including the COVID-19 Technology Access Pool, the People’s Vaccine Alliance demands that all vaccines, treatments and tests be monopoly-free, mass produced, distributed fairly and made available to all people, in all countries, free of charge.

“The People’s Vaccine will go far in levelling the power dynamics that perpetuate inequality and fuel injustice and it will ensure that no one is left behind,” said Edward Kallon, United Nations Resident Coordinator and Humanitarian Coordinator in Nigeria. “Nobody should be denied a COVID-19 vaccine because of where they live or how much money they have—it has to be a global public good, available to all who need it, regardless of their situation.”

The People’s Vaccine Alliance is calling on pharmaceutical corporations and governments to:

• Prevent monopoly on vaccine production by making public funding for research and development conditional on research institutions and pharmaceutical companies sharing all information, data, biological material, know-how and intellectual property. The WHO COVID-19 Technology Access Pool provides the mechanism for such sharing.
• Prevent monopoly on vaccine supply by enabling as many manufacturers as possible, including in developing countries, to produce the vaccines.
• Implement fair allocation of the vaccine that prioritizes health workers and other at-risk groups in all countries. Vaccination programmes should include marginalized groups, including refugees, prisoners and people living in slums and other crowded housing conditions. Allocation between and within countries should be based on need and not ability to pay.
• Provide the vaccine free of charge at the point of use.
• Ensure the full participation of the governments of developing countries as well as global civil society in decision-making forums about the vaccines (and other COVID-19 technologies) and ensure transparency and accountability of all decisions.

To date, the People’s Vaccine has been endorsed by more than 140 leaders and advocates globally, including the President of South Africa and the Chairperson of the African Union Commission, the Presidents of Ghana and Senegal, the Prime Minister of Pakistan, the Director of the Africa Centres for Disease Control and Prevention and the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.

The People’s Vaccine Alliance

The People’s Vaccine Alliance is a coalition of organisations and activists united under a common aim of campaigning for a People’s Vaccine’ for COVID-19 that is based on shared knowledge and is freely available for all. A global common good. It is coordinated by Oxfam and UNAIDS and its other members include: Free the Vaccine, Frontline AIDS, Global Justice Now, International Treatment Preparedness Coalition, Just Treatment, Nizami Ganjavi International Center, Open Society Foundations, STOPAIDS, SumOfUs, Wemos and Yunus Centre.

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.